Medical Comorbidities in Late-Life Depression

Late-life depression is both underrecognized and undertreated, and the impact of medical comorbidity may mask depressive symptoms. Depression further complicates the prognosis of medical illness by increasing physical disability and decreasing motivation and adherence to prescribed medications and/or exercise or rehabilitation programs

[1]  N. Frasure-smith,et al.  Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. , 2008, Archives of general psychiatry.

[2]  H. Allain,et al.  Depression in Parkinson's disease , 2000, BMJ : British Medical Journal.

[3]  G. Dell''Agnello,et al.  SSRIs Do Not Worsen Parkinson's Disease: Evidence from an Open-Label, Prospective Study , 2001, Clinical neuropharmacology.

[4]  M. Whooley,et al.  Depression and Inflammation in Patients With Coronary Heart Disease: Findings from the Heart and Soul Study , 2007, Biological Psychiatry.

[5]  Michael Sharpe,et al.  Depression after stroke and lesion location: a systematic review , 2000, The Lancet.

[6]  H. Kuper,et al.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. , 2006, European heart journal.

[7]  G. Alexopoulos,et al.  Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[8]  P. Wolf,et al.  Depressive Symptoms and Risk of Stroke: The Framingham Study , 2007, Stroke.

[9]  J. Cummings,et al.  Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.

[10]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[11]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[12]  A. Glassman,et al.  Treatment of Depression in Patients with Heart Disease , 1998 .

[13]  M. Sitzer,et al.  Post-Stroke-Depression , 2005, Fortschritte der Neurologie-Psychiatrie.

[14]  A. Sharafkhaneh,et al.  COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial , 2007, Psychological Medicine.

[15]  J. Spertus,et al.  The prevalence of unrecognized depression in patients with acute coronary syndrome. , 2006, American heart journal.

[16]  M. Roizen,et al.  Examining a Bidirectional Association Between Depressive Symptoms and Diabetes , 2009 .

[17]  Hochang B. Lee,et al.  Cerebrovascular disease basis of depression: Post-stroke depression and vascular depression , 2006, International review of psychiatry.

[18]  N. Fedorova,et al.  Use of the dopamine receptor agonist Mirapex in the treatment of Parkinson’s disease , 2007, Neuroscience and Behavioral Physiology.

[19]  B. Mulsant,et al.  Post stroke depression: epidemiology, pathophysiology, and biological treatment , 2002, Biological Psychiatry.

[20]  R. Alterman,et al.  Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulation. , 2008, The Mount Sinai journal of medicine, New York.

[21]  K. Cook,et al.  Prevalence and treatment of depression in Parkinson's disease. , 2005, The Journal of neuropsychiatry and clinical neurosciences.

[22]  R. Robinson,et al.  Poststroke depression: prevalence, diagnosis, treatment, and disease progression , 2003, Biological Psychiatry.

[23]  S. Machale.  Managing depression in physical illness , 2002 .

[24]  J. Jankovic,et al.  The impact of depressive symptoms in early Parkinson disease , 2007, Neurology.

[25]  Y. Gustafson,et al.  Epidemiology and Treatment of Post-Stroke Depression , 1995, Drugs & aging.

[26]  C. Pantelis,et al.  The Positive Effect of Integrated Care on Depressive Symptoms in Stroke Survivors , 2008, Cerebrovascular Diseases.

[27]  Y. Conwell.  Suicide in later life: a review and recommendations for prevention. , 2001, Suicide & life-threatening behavior.

[28]  A. Yohannes,et al.  Mood disorders in elderly patients with chronic obstructive pulmonary disease , 2000 .

[29]  A. Yohannes,et al.  Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire , 2000, International journal of geriatric psychiatry.

[30]  J. O'Brien,et al.  Vascular basis of late-onset depressive disorder , 2002, British Journal of Psychiatry.

[31]  J. Cummings,et al.  Depression in patients with Parkinson's disease , 1999, International journal of geriatric psychiatry.

[32]  Jonathan Rottenberg,et al.  Cardiac vagal control in depression: A critical analysis , 2007, Biological Psychology.

[33]  M. Kunik,et al.  One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease , 2001, Psychological Medicine.

[34]  R. Pauwels,et al.  Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.

[35]  M. Fava,et al.  A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. , 2005, The Journal of clinical psychiatry.

[36]  M. Irwin,et al.  Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes , 2007, Biological Psychiatry.

[37]  R G Robinson,et al.  Lesion location and poststroke depression. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[38]  R. Robinson,et al.  A two‐year longitudinal study of post‐stroke mood disorders: findings during the initial evaluation. , 1983, Stroke.

[39]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[40]  N. Schneiderman,et al.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.

[41]  A. House,et al.  Pharmaceutical interventions for emotionalism after stroke. , 2019, The Cochrane database of systematic reviews.

[42]  G. Alexopoulos.  The Vascular Depression Hypothesis: 10 Years Later , 2006, Biological Psychiatry.

[43]  H. Hanger.  Emotionalism after stroke , 1993, The Lancet.

[44]  A. Yohannes,et al.  Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. , 2005, Age and ageing.

[45]  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.

[46]  R. Allegri,et al.  A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression” , 2005, International Psychogeriatrics.

[47]  C. Lyketsos,et al.  Mood Disorders in the Medically Ill: Scientific Review and Recommendations , 2005, Biological Psychiatry.

[48]  J. Cummings,et al.  Risk factors for depression in Parkinson disease. , 1997, Archives of neurology.

[49]  Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina , 2002 .

[50]  R. Carney,et al.  Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. , 2007, Journal of psychosomatic research.

[51]  G. Alexopoulos,et al.  Clinically defined vascular depression. , 1997, The American journal of psychiatry.

[52]  K. Krishnan,et al.  Psychiatric Disease in the Twenty-First Century: The Case for Subcortical Ischemic Depression , 2006, Biological Psychiatry.

[53]  C. O'connor,et al.  Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. , 2003, The American journal of cardiology.

[54]  P. Houghton,et al.  Leads from Indian medicinal plants with hypoglycemic potentials. , 2006, Journal of ethnopharmacology.

[55]  S. Kritchevsky,et al.  Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. , 2007, Archives of internal medicine.

[56]  Potential screening measures for depression and anxiety after stroke , 2006 .